Literature DB >> 11642274

Establishment and characterization of a new canine mast cell tumor cell line.

T Ishiguro1, T Kadosawa, K Mori, S Takagi, M Okumura, T Fujinaga.   

Abstract

A new cell line (CoMS) was established from a 3-year-old male mongrel dog with mast cell tumor of the oral mucosa. CoMS cells grow in suspension with a doubling time of 27.0 +/- 0.7 hr. The cytoplasmic granules were formalin-sensitive, showed diverse appearances in their ultrastructural findings and contained heparin proteoglycan and neutral protease chymase. Calcium ionophore A23187, substance P and concanavalin A caused significant histamine release from CoMS cells, while compound 48/80 failed to release histamine. This cell line will make an available source for studies on canine mast cell tumors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11642274     DOI: 10.1292/jvms.63.1031

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


  9 in total

1.  In vitro inhibitory effect of trichostatin A on canine grade 3 mast cell tumor.

Authors:  Marcia Kazumi Nagamine; Daniel S Sanches; Katia C Pinello; Luciana Neves Torres; Gregory Mennecier; Andréia O Latorre; Heidge Fukumasu; Maria Lucia Zaidan Dagli
Journal:  Vet Res Commun       Date:  2011-04-07       Impact factor: 2.459

2.  In vitro chemosensitivity of canine mast cell tumors grades II and III to all-trans-retinoic acid (ATRA).

Authors:  K C Pinello; M Nagamine; T C Silva; P Matsuzaki; H V Caetano; L N Torres; H Fukumasu; J L Avanzo; J M Matera; M L Z Dagli
Journal:  Vet Res Commun       Date:  2009-01-14       Impact factor: 2.459

3.  The radiosensitizing effect of the aurora kinase inhibitors, ENMD-2076, on canine mast cell tumours in vitro.

Authors:  K Shiomitsu; E Sajo; C Rubin; I Sehgal
Journal:  Vet Comp Oncol       Date:  2013-06-13       Impact factor: 2.613

4.  Oncolytic reovirus in canine mast cell tumor.

Authors:  Chung Chew Hwang; Saori Umeki; Masahito Kubo; Toshiharu Hayashi; Hiroshi Shimoda; Masami Mochizuki; Ken Maeda; Kenji Baba; Hiroko Hiraoka; Matt Coffey; Masaru Okuda; Takuya Mizuno
Journal:  PLoS One       Date:  2013-09-20       Impact factor: 3.240

5.  Intercellular interactions between mast cells and stromal fibroblasts obtained from canine cutaneous mast cell tumours.

Authors:  Lidia H Pulz; Yonara G Cordeiro; Greice C Huete; Karine G Cadrobbi; Arina L Rochetti; Pedro L P Xavier; Adriana Tomoko Nishiya; Silvio Henrique de Freitas; Heidge Fukumasu; Ricardo F Strefezzi
Journal:  Sci Rep       Date:  2021-12-13       Impact factor: 4.379

6.  Antitumor activity of the dual PI3K/mTOR inhibitor gedatolisib and the involvement of ABCB1 in gedatolisib resistance in canine tumor cells.

Authors:  Yusuke Murase; Kenji Hosoya; Takachika Sato; Sangho Kim; Masahiro Okumura
Journal:  Oncol Rep       Date:  2022-01-28       Impact factor: 3.906

7.  NI-1: a novel canine mastocytoma model for studying drug resistance and IgER-dependent mast cell activation.

Authors:  E Hadzijusufovic; B Peter; H Herrmann; T Rülicke; S Cerny-Reiterer; K Schuch; L Kenner; T Thaiwong; V Yuzbasiyan-Gurkan; W F Pickl; M Willmann; P Valent
Journal:  Allergy       Date:  2012-05-15       Impact factor: 13.146

8.  Expression of PD-L1 on canine tumor cells and enhancement of IFN-γ production from tumor-infiltrating cells by PD-L1 blockade.

Authors:  Naoya Maekawa; Satoru Konnai; Ryoyo Ikebuchi; Tomohiro Okagawa; Mami Adachi; Satoshi Takagi; Yumiko Kagawa; Chie Nakajima; Yasuhiko Suzuki; Shiro Murata; Kazuhiko Ohashi
Journal:  PLoS One       Date:  2014-06-10       Impact factor: 3.240

9.  Functional analysis of CD44 variants and xCT in canine tumours.

Authors:  Atsushi Tanabe; Kento Kimura; Hana Tazawa; Takuya Maruo; Masayuki Taguchi; Hiroeki Sahara
Journal:  Vet Med Sci       Date:  2020-11-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.